Top Markets
Coin of the day
Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX
Rangering i aksjer #20612
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Aksjekurs
$22.52
Markedsverdi
$124.60M
Endring (1 dag)
0.00%
Endring (1 år)
-21.94%
Land
PL
Handel Bioceltix S.a. (BCX)

Kategori

Historikk for aksjesplitt for Bioceltix S.a. (BCX)
Aksjen Bioceltix S.a. (symbol: BCX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 24, 2026.
Én BCX-aksje kjøpt før Aug 24, 2026 tilsvarer i dag 0 BCX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH